SCHEMBL18850877

SCHEMBL18850877

NC(=O)c1cn(C2CCCCCCC2)nn1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PSMB8 P28062 8/20 0.54
PSMB5 P28074 8/20 0.54
PSMB9 P28065 4/20 0.54
SMYD3 Q9H7B4 1/20 0.50
ACHE P22303 3/20 0.38
BTK Q06187 1/20 0.38
HRH4 Q9H3N8 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
HDAC10 Q969S8 1/20 0.37
HDAC8 Q9BY41 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
SCD O00767 1/20 0.36
CA5A P35218 1/20 0.36
DPP4 P27487 1/20 0.35
ACKR3 P25106 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18850919 1.00 PSMB8 (0.54) PSMB8PSMB5PSMB9SMYD3ACHE
SCHEMBL19691215 0.91 SMYD3 (0.57) PSMB8PSMB5PSMB9SMYD3HDAC3
SCHEMBL21789270 0.85 SMYD3 (0.68) PSMB8PSMB5PSMB9SMYD3HDAC3
SCHEMBL30999011 0.84 SMYD3 (0.48) PSMB8PSMB5PSMB9SMYD3HDAC3
SCHEMBL71503 0.83 PSMB8 (0.53) PSMB8PSMB5PSMB9SMYD3ACHE
SCHEMBL29592982 0.80 SMYD3 (0.43) PSMB8PSMB5PSMB9SMYD3HDAC3
SCHEMBL24785692 0.78 PSMB8 (0.51) PSMB8PSMB5PSMB9SMYD3ACHE
SCHEMBL892462 0.76 PSMB8 (0.54) PSMB8PSMB5PSMB9
SCHEMBL70303 0.75 SMYD3 (0.55) PSMB8PSMB5PSMB9SMYD3HDAC3
SCHEMBL24784759 0.74 PSMB8 (0.52) PSMB8PSMB5PSMB9SMYD3ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11678659-B2 Use as rodenticides of compounds that inhibit blood coagulation GULBA DIETRICH (DE) 2023-06-20 US disclosed
US-20170127667-A1 USE AS RODENTICIDES OF COMPOUNDS THAT INHIBIT BLOOD COAGULATION GULBA DIETRICH (DE) 2017-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11678659-B2 Use as rodenticides of compounds that inhibit blood coagulation PLAT, F2R, PLAUR PSMB8 2178/4885PSMB5 1781/4885PSMB9 1489/4885
US-20170127667-A1 USE AS RODENTICIDES OF COMPOUNDS THAT INHIBIT BLOOD COAGULATION PLAT, F2R, PLAUR PSMB8 2178/4885PSMB5 1781/4885PSMB9 1489/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.